Primary outcome (treatment failure) in patients randomised to the two study groups
| MD group (n = 52) | DD group (n = 46) | |
|---|---|---|
| MD = maintenance dose group; DD = double dose group; CS = corticosteroid. | ||
| Asthma instability | 12 (23%) | 6 (13%) |
| Oral CS | 4 (8%) | 7 (15%) |
| Oral CS and instability | 4 (8%) | 3 (7%) |
| Oral CS, visit and instability | 1 (2%) | 1 (2%) |
| Oral CS and unscheduled visit | 0 (0%) | 1 (22%) |
| Unscheduled visit | 0 (0%) | 1 (2%) |
| Total | 21 (40%) | 19 (41%) |